Delivery Order SPE2DB24D1021-SPE2DB25FFALR
- Not listed
- The Defense Logistics Agency awarded a $18,879.92 delivery order to AmerisourceBergen Drug Corp for Prograf 1 mg capsules (100-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and autoimmune disease management, representing part...
- The Defense Logistics Agency awarded a delivery order valued at $36,127.45 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,107.15 contract is for the delivery of Prograf 1 mg capsules, a specialty medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Prograf 1 mg capsules, a medication used for organ transplant rejection prevention. The contract has a firm fixed price, with a ceiling value of $3,280 and a period of performance through November 12, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract...
- This is a $1,303.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROGRAF 1 MG CAPSULE 100S, with a period of performance through May 30, 2025. The contract is not set aside and was awarded on an open competition basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $2,460.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prograf 1 mg capsules, a medication used to prevent organ rejection in transplant patients. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a $3,946.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of the prescription medication Prograf in a 5 mg dosage. The delivery order was issued under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 13-14, 2023. No...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a contract ceiling value of $1,206.33. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a ceiling value of $1,038.82. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and has an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation...
- This federal contract award is a delivery order worth $1,589.62 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through October 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFALRDelivery Order
This delivery order, awarded September 9, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 100 capsules of Prograf 1 mg, an immunosuppressant medication, with a ceiling value of $3,954.26 and completion date of September 10, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/9/25 |